GlassScriptPhysician profile
Holly H Wolf
NPI 1124370333
$3,397.59
in general payments reported to CMS, 2019-2025
14 companies · $342 in 2025
The $342 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $332 · 2022: $621 · 2023: $396 · 2024: $1,707 · 2025: $342.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,203 · Consulting Fee: $1,063 · Education: $179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,202.96 |
| Consulting Fee | $1,062.50 |
| Education | $178.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,414.33 | 2022-2024 | Tremfya |
| Novartis Pharmaceuticals Corporation | $533.44 | 2022-2025 | |
| Sun Pharmaceutical Industries INC. | $514.26 | 2021-2024 | Ilumya |
| Regeneron Healthcare Solutions, INC. | $272.70 | 2021-2024 | Dupixent |
| Abbvie INC. | $200.06 | 2022-2024 | |
| Galderma Laboratories, L.P. | $144.29 | 2022-2025 | Nemluvio |
| Leo Pharma INC. | $109.80 | 2023-2025 | Adbry |
| Lilly USA, LLC | $55.58 | 2021-2022 | |
| Ucb, INC. | $40.01 | 2021-2023 | Cimzia |
| Organon LLC | $27.03 | 2024 | |
| Genzyme Corporation | $25.92 | 2022 | |
| Amgen INC. | $25.43 | 2023 | Otezla |
| Dermavant Sciences, INC. | $18.28 | 2023 | Vtama |
| Incyte Corporation | $16.46 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Holly Wolf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.